High levels indicate decreased clearance of cholesterol from the blood. Genetics highly influence ApoB. It's associated with heart disease, stroke, and overall lifespan. You can modify your ApoB, meaning dietary changes and supplement intake can help improve your levels. What...
Clinically and lipid-adjusted models also included apolipoprotein B, non–high-density lipoprotein cholesterol, triglycerides, and high-density lipoprotein cholesterol in addition to the clinical variables. Figure 2. Relative Importance of Lipoprotein Type After Adjusting for Apolipoprotein B Concentration in...
"Pattern I," meaning "intermediate," indicates that most LDL particles are very close in size to the normal gaps in the endothelium (26 nm). The healthiest pattern, though relatively rare, is to have small numbers of large LDL particles and no small particles. Having small LDL particles, ...
Though apo B and non-HDL-C are moderately correlated, they can be highly discordant among some individuals. Several predictors can help identify patients with discordant values; however, the clinical meaning (i.e., CV risk) of a high apo B compared to non-HDL-C (or vise versa) remains ...
In males, the striatum and thalamus did not show significant 125I-insulin transport, meaning there was not a statistically significant relation between the brain/serum (B/S) ratio and exposure time (Supplementary Table 2). The hypothalamus and hippocampus also did not exhibit 125I-insulin ...
Fig. 1. Changes in retinyl palmitate, apolipoprotein B-48, apolipoprotein B-100, and triglyceride concentrations after the ingestion of the high fat load. Concentrations were measured in the three fractions of triglyceride-rich lipoproteins (Sf < 400, Sf 60–400, and Sf 20–60). Data are mea...
If the Nfs for one polymorphism was smaller than the number of observed studies for that polymorphism, this was inter- preted as meaning that the meta-analysis result of that particular genetic the Nfs sviganriiafinctanmciegwhtasheasvteabalissihgendifiactaPn¼t 0p.u0b5lÂic(aNtiofsn0.0...
14. A method for screening for prostate cancer or benign prostate hyperplasia in a subject comprising the steps of: (a) providing a biological sample of a human physiological fluid or prostate tissue from the subject; (b) detecting or determining absence, presence or amount of an ApoA-II isof...
Unless otherwise indicated, the following definitions are set forth to illustrate and define the meaning and scope of the various terms used to describe the invention herein. “Left ventricular diastolic dysfunction” or “LVDD” as used herein mean an abnormality in the filling of the left ventric...
and b) determining the effect, if any, of the test agent on the level of the unprocessed apoE nucleic acid relative to the level of processed apoE nucleic acid, compared to the level of unprocessed apoE nucleic acid relative to the level of processed apoE nucleic acid in a control cell co...